OUR PRODUCTS

MOBILE APPS

GENERAL INFO

CUE

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Cue Biopharma (CUE) Earnings Date & Reports

Cue Biopharma Inc is a clinical-stage biopharmaceutical company... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

CUE is expected to report earnings to fall 17.65% to -14 cents per share on September 08

Cue Biopharma CUE Stock Earnings Reports

Q2'25

Est.

$-0.14

Q1'25

Missed

by $0.01

Q4'24

Missed

by $0.04

Q3'24

Beat

by $0.01

Q2'24

Beat

by $0.08

The last earnings report on May 13 showed earnings per share of -17 cents, missing the estimate of -15 cents. With 176.28K shares outstanding, the current market capitalization sits at 62.62M.

View a ticker or compare two or three

Compare

CUE

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For CUE
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. CUE showed earnings on May 13, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

a developer of biopharmaceuticals

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

40 Guest Street

Phone

+1 617 949-2680

Employees

Web

https://www.cuebiopharma.com